JP2012520269A5 - - Google Patents

Download PDF

Info

Publication number
JP2012520269A5
JP2012520269A5 JP2011553476A JP2011553476A JP2012520269A5 JP 2012520269 A5 JP2012520269 A5 JP 2012520269A5 JP 2011553476 A JP2011553476 A JP 2011553476A JP 2011553476 A JP2011553476 A JP 2011553476A JP 2012520269 A5 JP2012520269 A5 JP 2012520269A5
Authority
JP
Japan
Prior art keywords
amino
piperazin
thiazolo
fluorophenyl
pyrimidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011553476A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012520269A (ja
JP5647998B2 (ja
Filing date
Publication date
Priority claimed from GB0904353A external-priority patent/GB0904353D0/en
Priority claimed from GB0904373A external-priority patent/GB0904373D0/en
Priority claimed from GB0911022A external-priority patent/GB0911022D0/en
Application filed filed Critical
Priority claimed from PCT/EP2010/053318 external-priority patent/WO2010103130A2/en
Publication of JP2012520269A publication Critical patent/JP2012520269A/ja
Publication of JP2012520269A5 publication Critical patent/JP2012520269A5/ja
Application granted granted Critical
Publication of JP5647998B2 publication Critical patent/JP5647998B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011553476A 2009-03-13 2010-03-15 免疫抑制剤としてのチアゾロピリミジン調節因子 Expired - Fee Related JP5647998B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0904373.8 2009-03-13
GB0904353.0 2009-03-13
GB0904353A GB0904353D0 (en) 2009-03-13 2009-03-13 Novel thiazolopyrimidines
GB0904373A GB0904373D0 (en) 2009-03-13 2009-03-13 Novel thienopyrimidines
GB0911022A GB0911022D0 (en) 2009-06-26 2009-06-26 Novel purines
GB0911022.2 2009-06-26
PCT/EP2010/053318 WO2010103130A2 (en) 2009-03-13 2010-03-15 Novel bicyclic heterocycles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014228403A Division JP6021880B2 (ja) 2009-03-13 2014-11-10 免疫抑制剤としてのチアゾロピリミジン調節因子

Publications (3)

Publication Number Publication Date
JP2012520269A JP2012520269A (ja) 2012-09-06
JP2012520269A5 true JP2012520269A5 (cg-RX-API-DMAC7.html) 2013-05-02
JP5647998B2 JP5647998B2 (ja) 2015-01-07

Family

ID=42181129

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011553476A Expired - Fee Related JP5647998B2 (ja) 2009-03-13 2010-03-15 免疫抑制剤としてのチアゾロピリミジン調節因子
JP2014228403A Expired - Fee Related JP6021880B2 (ja) 2009-03-13 2014-11-10 免疫抑制剤としてのチアゾロピリミジン調節因子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014228403A Expired - Fee Related JP6021880B2 (ja) 2009-03-13 2014-11-10 免疫抑制剤としてのチアゾロピリミジン調節因子

Country Status (6)

Country Link
US (2) US8901132B2 (cg-RX-API-DMAC7.html)
EP (2) EP2923734B1 (cg-RX-API-DMAC7.html)
JP (2) JP5647998B2 (cg-RX-API-DMAC7.html)
CA (2) CA2754890C (cg-RX-API-DMAC7.html)
ES (2) ES2543216T3 (cg-RX-API-DMAC7.html)
WO (1) WO2010103130A2 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ574028A (en) 2006-07-05 2010-10-29 Fibrotech Therapeutics Pty Ltd Tranilast analogues (substituted cinnamoyl anthranilate compounds) for treatment of conditions associated with firbrosis
EP2923734B1 (en) * 2009-03-13 2018-01-10 Katholieke Universiteit Leuven, K.U. Leuven R&D Purine analogues and their use as immunosuppressive agents
EP2947073B1 (en) * 2009-10-22 2019-04-03 Fibrotech Therapeutics Pty Ltd Fused ring analogues of anti-fibrotic agents
GB201012889D0 (en) * 2010-08-02 2010-09-15 Univ Leuven Kath Antiviral activity of novel bicyclic heterocycles
GB201015411D0 (en) * 2010-09-15 2010-10-27 Univ Leuven Kath Anti-cancer activity of novel bicyclic heterocycles
GB201114212D0 (en) 2011-08-18 2011-10-05 Ucb Pharma Sa Therapeutic agents
GB201115665D0 (en) 2011-09-09 2011-10-26 Univ Leuven Kath Autoimmune and inflammatory disorder therapy
US20130102601A1 (en) 2011-10-21 2013-04-25 F. Hoffmann-La Roche Ltd Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral disease
GB201119401D0 (en) 2011-11-10 2011-12-21 Ucb Pharma Sa Therapeutic agents
GB201217704D0 (en) 2012-10-03 2012-11-14 Ucb Pharma Sa Therapeutic agents
EA027752B1 (ru) * 2012-12-20 2017-08-31 Юсб Биофарма Спрл Терапевтически активные производные пиразолопиримидина
CN103044460B (zh) * 2013-01-30 2015-02-25 石家庄学院 3,5,7-三苯基-5H-噻唑并[3,2-a]嘧啶类衍生物及应用
EP2981289A1 (en) * 2013-04-05 2016-02-10 Polichem SA Use of pidotimod to treat inflammatory bowel disease
EP3049086A4 (en) * 2013-09-27 2017-02-22 Nimbus Iris, Inc. Irak inhibitors and uses thereof
TWI648281B (zh) 2013-10-17 2019-01-21 日商安斯泰來製藥股份有限公司 含硫二環式化合物
CN104892589A (zh) * 2014-03-07 2015-09-09 中国科学院上海药物研究所 一类杂环化合物、其制备方法和用途
GB201410817D0 (en) * 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R & D Therapeutic agents
US9822127B2 (en) * 2014-07-23 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University GAK modulators as antivirals
UY36390A (es) * 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
EA201790806A1 (ru) 2014-11-05 2017-11-30 Флексус Байосайенсиз, Инк. Иммунорегулирующие средства
GB201517263D0 (en) 2015-09-30 2015-11-11 Ucb Biopharma Sprl And Katholieke Universiteit Leuven Therapeutic agents
GB201521767D0 (en) 2015-12-10 2016-01-27 Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R&D Therapeutic agents
EP3577103A1 (en) 2017-02-03 2019-12-11 Certa Therapeutics Pty Ltd. Anti-fibrotic compounds
TWI811428B (zh) 2018-08-21 2023-08-11 日商杏林製藥股份有限公司 雙環雜芳香環衍生物

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2512572A (en) 1950-06-20 Substituted pteridines and method
BE791242A (fr) * 1971-11-11 1973-05-10 Thomae Gmbh Dr K Nouvelles thiazolo(5,4-d)pyrimidines
US4127118B1 (en) 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
ZA857647B (en) * 1984-10-12 1986-05-28 Warner Lambert Co Purine derivatives
NZ225447A (en) * 1987-07-20 1991-12-23 Merck & Co Inc Piperazinyl derivatives of purine and purine isosteres and pharmaceutical compositions
US5057517A (en) * 1987-07-20 1991-10-15 Merck & Co., Inc. Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
GB9221220D0 (en) 1992-10-09 1992-11-25 Sandoz Ag Organic componds
US5780462A (en) 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
JP2001097979A (ja) * 1999-07-28 2001-04-10 Takeda Chem Ind Ltd 縮合複素環化合物、その製造法および用途
US6331547B1 (en) 1999-08-18 2001-12-18 American Home Products Corporation Water soluble SDZ RAD esters
DE60101372T2 (de) * 2000-02-11 2004-10-14 Astrazeneca Ab Pyrimidinverbindungen und ihre verwendung als modulatoren der chemokin-rezeptor-aktivität
US6440991B1 (en) 2000-10-02 2002-08-27 Wyeth Ethers of 7-desmethlrapamycin
JP2004028376A (ja) 2002-06-21 2004-01-29 Hino Motors Ltd Egrクーラ
AU2003284142A1 (en) * 2002-10-15 2004-05-04 Synta Pharmaceuticals Corp Aromatic bicyclic heterocyles to modulate 1L-12 production
AU2003302657B8 (en) * 2002-12-04 2009-12-03 Eisai R&D Management Co., Ltd. Fused 1,3-dihydroimidazole ring compounds
ES2217956B1 (es) * 2003-01-23 2006-04-01 Almirall Prodesfarma, S.A. Nuevos derivados de 4-aminotieno(2,3-d)pirimidin-6-carbonitrilo.
CN1823071B (zh) 2003-06-11 2012-12-19 润生有限公司 用作钾通道抑制剂的噻吩并嘧啶衍生物
DE10348023A1 (de) * 2003-10-15 2005-05-19 Imtm Gmbh Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
JPWO2005095419A1 (ja) 2004-04-01 2008-02-21 武田薬品工業株式会社 チアゾロピリミジン誘導体
GB0407723D0 (en) * 2004-04-05 2004-05-12 Novartis Ag Organic compounds
US7576080B2 (en) 2004-12-23 2009-08-18 Memory Pharmaceuticals Corporation Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors
FR2880626B1 (fr) * 2005-01-13 2008-04-18 Aventis Pharma Sa Derives de la purine, compositions les contenant et utilisation
CA2595882A1 (en) * 2005-01-26 2006-08-03 Pharmacia & Upjohn Company Llc Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation
CN101248074A (zh) 2005-07-01 2008-08-20 日本化学医药株式会社 黄嘌呤氧化酶抑制剂
GB0526246D0 (en) * 2005-12-22 2006-02-01 Novartis Ag Organic compounds
US20080108611A1 (en) 2006-01-19 2008-05-08 Battista Kathleen A Substituted thienopyrimidine kinase inhibitors
KR100846988B1 (ko) 2006-03-06 2008-07-16 제일약품주식회사 신규한 티에노피리미딘 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법 및 이를 함유하는 약학조성물
AU2007243466B2 (en) * 2006-04-26 2012-01-19 F. Hoffmann-La Roche Ag Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
KR101077295B1 (ko) * 2006-05-18 2011-10-26 에프. 호프만-라 로슈 아게 아데노신 a2b 수용체 길항물질로서의 티아졸로-피라미딘/피리딘 우레아 유도체
US20080004253A1 (en) * 2006-06-30 2008-01-03 Bryan James Branstetter Thiazolopyrimidine modulators of TRPV1
ME02789B (me) 2006-08-08 2011-06-30 Millennium Pharm Inc Jedinjenja heteroarila korisna kao inhibitori e1 aktivirajućih enzima
WO2008057402A2 (en) * 2006-11-02 2008-05-15 Cytovia, Inc. N-aryl-isoxazolopyrimidin-4-amines and related compounds as activators of caspases and inducers of apoptosis and the use thereof
KR20100014271A (ko) 2006-11-16 2010-02-10 파마코페이아, 엘엘씨. 면역 억제를 위한 7-치환된 퓨린 유도체
WO2008059368A2 (en) 2006-11-17 2008-05-22 Pfizer Products Inc. Fused 2-amino pyrimidine compounds and their use for the treatment of cancer
CA2671845C (en) * 2006-12-07 2015-03-24 Genentech, Inc. Phosphoinositide 3-kinase inhibitor compounds and methods of use
BRPI0806811A2 (pt) 2007-01-23 2011-09-13 Palau Pharma Sa derivados de purina
CA2676138A1 (en) 2007-01-26 2008-08-07 Irm Llc Compounds and compositions as kinase inhibitors
WO2008135232A1 (en) 2007-05-02 2008-11-13 Riccardo Cortese Use and compositions of purine derivatives for the treatment of proliferative disorders
ATE510841T1 (de) * 2007-06-12 2011-06-15 Hoffmann La Roche Thiazoliopyrimidine und ihre verwendung als hemmer der phosphatidylinositol-3 kinase
EP2170888B1 (en) 2007-06-29 2015-04-22 Gilead Sciences, Inc. Purine derivatives and their use as modulators of toll-like receptor 7
WO2009013545A2 (en) * 2007-07-26 2009-01-29 Astrazeneca Ab Chemical compounds
WO2009027732A1 (en) * 2007-08-24 2009-03-05 Astrazeneca Ab 5-6-bicyclic heteroaromatic compounds with antibacterial activity
CN101932587A (zh) * 2007-09-24 2010-12-29 吉宁特有限公司 噻唑并嘧啶pi3k抑制剂化合物及使用方法
UA104010C2 (en) * 2008-12-18 2013-12-25 Эли Лилли Энд Компани Purine compounds
EP2923734B1 (en) * 2009-03-13 2018-01-10 Katholieke Universiteit Leuven, K.U. Leuven R&D Purine analogues and their use as immunosuppressive agents
AR080711A1 (es) * 2010-03-31 2012-05-02 Lilly Co Eli Compuesto de piperazin-purina composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento o prevencion del dolor

Similar Documents

Publication Publication Date Title
JP6021880B2 (ja) 免疫抑制剤としてのチアゾロピリミジン調節因子
US9730944B2 (en) Antiviral activity of novel bicyclic heterocycles
EP2616077A1 (en) Anti-cancer activity of novel bicyclic heterocycles
RU2336275C2 (ru) Пиримидопроизводные, характеризующиеся антипролиферативной активностью, и фармацевтическая композиция
SI3106463T1 (en) Substituted pyrazolo(1,5-)pyrimidine compounds as trk kinase inhibitors
CA2473026A1 (en) 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
JP2012501312A5 (cg-RX-API-DMAC7.html)
JP2012532131A5 (cg-RX-API-DMAC7.html)
JP2016515098A5 (cg-RX-API-DMAC7.html)
CN108366992A (zh) 蛋白水解靶向嵌合体化合物及其制备和应用方法
RU2008107879A (ru) Ингибиторы цитокинов
CA2385269A1 (en) Novel thiazolo(4,5-d)pyrimidine compounds
CA2407593A1 (en) Fused heteroaryl derivatives
MX2010001677A (es) Derivados de 4-(9-(3,3-difluorociclopentil)-5,7,7-trimetil-6-oxo-6 ,7,8,9-tetrahidro-5h-pirimido[4,5-b][1,4]diazepin-2-ilamino)-3-me toxibenzamida como inhibidores de las proteinas cinasas humanas plk1 a plk4 para el tratamiento de enfermedades proli
RU2005101406A (ru) Производные пиримидинсульфонамида в качестве модуляторов рецепторов хемокинов
JP2003528880A5 (cg-RX-API-DMAC7.html)
JP2018515526A5 (cg-RX-API-DMAC7.html)
JP2017501983A5 (cg-RX-API-DMAC7.html)
RU2014109748A (ru) Морфолино-замещенные производные бициклических пиримидинмочевины или карбамата в качестве ингибиторов mtor
JP2005513020A5 (cg-RX-API-DMAC7.html)
FI3909584T3 (fi) Pyrimidiiniyhdiste tai sen suola
JP2006512366A5 (cg-RX-API-DMAC7.html)
PE20061193A1 (es) DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2-[1H]-0NA COMO INHIBIDORES DE QUINASA p38
RU2004110042A (ru) Тиено[2,3-d] пиримидины с комбинированной агонистической активностью lh и fsh
RU2016109792A (ru) Новые соединения-антагонисты рецептора нейрокинина-1